Sign in

Cullinan Therapeutics, Inc.

Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-16 Dec-15 Dec-14 Dec-13 Dec-12
Total revenue 0.00 0.00 0.00 0.00 0.02 0.02 0.00 0.00 0.00 0.00 0.00 0.00
Cost of revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Gross profit 0.00 0.00 0.00 0.00 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total operating expenses + 0.24 0.20 0.19 -0.14 0.09 0.06 0.02 0.01 0.00 0.00 0.00 0.00
Operating income -0.24 -0.20 -0.19 0.14 -0.07 -0.06 -0.02 -0.01 0.00 0.00 0.00 0.00
Non-operating income (net) 0.02 0.03 0.02 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax -0.22 -0.17 -0.17 0.15 -0.07 -0.06 -0.02 -0.01 0.00 0.00 0.00 0.00
Income tax expense 0.00 -0.01 0.04 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.00
Net income -0.22 -0.17 -0.15 0.11 -0.07 -0.05 -0.02 -0.01 0.00 0.00 0.00 0.00
Show Quarterly Income Statement
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-16 Sep-16 Jun-16 Mar-16 Dec-15 Sep-15 Jun-15 Mar-15 Dec-14 Sep-14 Jun-14 Mar-14 Dec-13 Sep-13 Jun-13 Mar-13 Dec-12 Sep-12 Jun-12 Mar-12
Total revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.04 0.00 0.00 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cost of revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Gross profit 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.04 0.00 0.00 0.02 0.00 0.00 0.00 0.00 0.00 0.00
Total operating expenses + 0.05 0.06 0.06 0.08 0.05 0.06 0.05 0.05 0.04 0.05 0.05 0.04 0.06 0.03 0.03 -0.24 0.03 0.03 0.02 0.02 0.02 0.03 0.01 0.01 0.01 0.00 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Operating income -0.05 -0.06 -0.06 -0.08 -0.05 -0.06 -0.05 -0.05 -0.04 -0.05 -0.05 -0.04 -0.06 -0.03 -0.03 0.24 -0.03 -0.03 -0.02 -0.02 0.00 -0.03 -0.01 -0.01 -0.01 0.00 -0.01 -0.01 -0.01 0.00 0.00 0.00 0.00 0.00 0.00
Non-operating income (net) 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax -0.05 -0.05 -0.05 -0.07 -0.05 -0.05 -0.04 -0.04 -0.04 -0.04 -0.04 -0.03 -0.06 -0.03 -0.03 0.24 -0.03 -0.03 -0.02 -0.02 0.00 -0.03 -0.01 -0.01 -0.01 0.00 -0.01 -0.01 -0.01 0.00 0.00 0.00 0.00 0.00 0.00
Income tax expense 0.00 0.00 -0.01 -0.01 -0.01 0.00 0.00 0.00 0.07 -0.02 0.00 0.00 0.00 0.00 0.01 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net income -0.05 -0.05 -0.05 -0.07 -0.05 -0.05 -0.04 -0.04 -0.04 -0.02 -0.04 -0.03 -0.06 -0.03 -0.02 0.17 -0.01 -0.03 -0.02 -0.02 0.00 -0.03 -0.01 -0.01 0.00 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
5 days ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-16 Dec-15 Dec-14 Dec-13 Dec-12
Total cash and short-term investments + 0.38 0.40 0.47 0.47 0.29 0.21 0.10 0.03 0.00 0.00 0.00 0.00 0.00
Accounts receivable, net 0.00 0.01 0.00 0.00 0.00
Inventories -0.01
Other current assets 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Total current assets 0.39 0.41 0.48 0.47 0.30 0.21 0.10 0.03 0.00 0.00 0.00 0.00
Total non-current assets + 0.06 0.21 0.00 0.09 0.14 0.00 0.00 0.00
Total assets 0.45 0.62 0.48 0.56 0.44 0.21 0.10 0.03 0.00 0.00 0.00 0.00 0.00
Total current liabilities + 0.04 0.03 0.03 0.02 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total non-current liabilities + 0.00 0.00 0.00 0.00 0.00 0.00 0.14 0.05
Total liabilities 0.04 0.03 0.03 0.03 0.01 0.01 0.14 0.06 0.00 0.00 0.00 0.00 0.00
Total stockholders' equity + 0.41 0.59 0.45 0.54 0.42 0.20 -0.04 -0.02 0.00 0.00 0.00 0.00 0.00
Common shares outstanding 59 54 42 47 44 44 1 1
Show Quarterly Balance Sheet
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-16 Sep-16 Jun-16 Mar-16 Dec-15 Sep-15 Jun-15 Mar-15 Dec-14 Sep-14 Jun-14 Mar-14 Dec-13 Sep-13 Jun-13 Mar-13 Dec-12 Sep-12 Jun-12 Mar-12
Total cash and short-term investments + 0.35 0.38 0.33 0.27 0.30 0.40 0.58 0.66 0.43 0.47 0.47 0.49 0.39 0.47 0.58 0.61 0.31 0.29 0.32 0.34 0.44 0.21 0.22 0.10 0.10 0.10 0.00 0.00 0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts receivable, net 0.00 0.01 0.00 0.00 0.00 0.00
Inventories -0.01
Other current assets 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total current assets 0.36 0.39 0.34 0.28 0.32 0.41 0.59 0.68 0.45 0.48 0.48 0.50 0.40 0.47 0.58 0.62 0.32 0.30 0.33 0.34 0.45 0.21 0.22 0.10 0.10 0.10 0.03 0.00 0.00 0.00 0.00 0.00 0.00
Total non-current assets + 0.04 0.06 0.14 0.24 0.26 0.21 0.06 0.00 0.00 0.00 0.02 0.02 0.12 0.09 0.04 0.04 0.12 0.14 0.12 0.12 0.03 0.00 0.00 0.00 -0.10 0.00 -0.03
Total assets 0.40 0.45 0.48 0.52 0.58 0.62 0.65 0.68 0.45 0.48 0.49 0.52 0.51 0.56 0.62 0.67 0.44 0.44 0.45 0.46 0.48 0.21 0.22 0.10 0.10 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total current liabilities + 0.04 0.04 0.03 0.03 0.03 0.03 0.02 0.02 0.02 0.03 0.02 0.02 0.03 0.02 0.03 0.06 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total non-current liabilities + 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.14
Total liabilities 0.04 0.04 0.03 0.03 0.03 0.03 0.03 0.02 0.02 0.03 0.03 0.02 0.03 0.03 0.03 0.06 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.14 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total stockholders' equity + 0.37 0.41 0.45 0.49 0.55 0.59 0.63 0.66 0.43 0.45 0.47 0.50 0.49 0.54 0.59 0.60 0.42 0.42 0.44 0.46 0.47 0.20 0.21 0.10 0.10 -0.04 0.03 0.00 0.00 0.00 0.00 0.00 0.00
Common shares outstanding 59 59 59 59 59 59 58 55 43 43 43 40 41 46 46 46 44 44 43 43 42 42 38 19 19 1 1 1 1
5 days ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-16 Dec-15 Dec-14 Dec-13 Dec-12
Operating cash flow + -0.18 -0.15 -0.13 -0.13 -0.04 -0.03 -0.02 -0.01 0.00 0.00 0.00 0.00
Cash flow from investing + 0.18 -0.14 0.04 0.25 -0.33 -0.01 -0.04 0.00
Cash flow from financing + 0.00 0.27 0.04 -0.03 0.27 0.14 0.09 0.00 0.00 0.00 0.00 0.00 0.00
Change in cash 0.01 -0.02 -0.06 0.10 -0.11 0.10 0.03 -0.01 0.00 0.00 0.00 0.00 0.00
Show Quarterly Cash Flow
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-16 Sep-16 Jun-16 Mar-16 Dec-15 Sep-15 Jun-15 Mar-15 Dec-14 Sep-14 Jun-14 Mar-14 Dec-13 Sep-13 Jun-13 Mar-13 Dec-12 Sep-12 Jun-12 Mar-12
Operating cash flow + -0.05 -0.04 -0.04 -0.06 -0.04 -0.04 -0.03 -0.04 -0.04 -0.02 -0.03 -0.03 -0.05 -0.02 -0.05 -0.03 -0.02 -0.02 -0.01 -0.02 0.00 -0.01 -0.01 -0.01 -0.01 0.00 -0.01 -0.01 -0.01 0.00 0.00 0.00 0.00 0.00 0.00
Cash flow from investing + 0.03 0.02 0.07 0.05 0.04 0.02 0.02 -0.19 0.01 0.05 -0.04 0.01 0.02 -0.03 -0.06 0.30 0.03 -0.02 -0.03 -0.15 -0.14 0.01 0.00 0.01 -0.03 -0.04 0.00 0.00 0.00
Cash flow from financing + 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.26 0.00 0.00 0.00 0.04 0.00 -0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.26 0.12 0.00 0.01 0.01 0.08 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Change in cash -0.01 -0.02 0.03 0.00 -0.01 -0.02 -0.01 0.04 -0.02 0.03 -0.08 0.02 -0.03 -0.09 -0.11 0.28 0.02 -0.03 -0.04 -0.17 0.13 0.13 -0.01 0.01 -0.02 0.04 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
5 days ago

Cullinan Therapeutics, Inc. (CGEM) - Change In Cash And Cash Equivalents

1Y 2Y 5Y Max
9 days ago

Cullinan Therapeutics, Inc. (CGEM) - Proceeds From Repurchase Of Equity

1Y 2Y 5Y Max
9 days ago

Cullinan Therapeutics, Inc. (CGEM) - Net Income

1Y 2Y 5Y Max
9 days ago

Cullinan Therapeutics, Inc. (CGEM) - Stock Based Compensation

1Y 2Y 5Y Max
9 days ago

Cullinan Therapeutics, Inc. (CGEM) - Cashflow From Financing

1Y 2Y 5Y Max
9 days ago

Cullinan Therapeutics, Inc. (CGEM) - Cashflow From Investment

1Y 2Y 5Y Max
9 days ago

Cullinan Therapeutics, Inc. (CGEM) - Capital Expenditures

1Y 2Y 5Y Max
9 days ago

Cullinan Therapeutics, Inc. (CGEM) - Depreciation Depletion And Amortization

1Y 2Y 5Y Max
9 days ago

Cullinan Therapeutics, Inc. (CGEM) - Operating Cashflow

1Y 2Y 5Y Max
9 days ago

Cullinan Therapeutics, Inc. (CGEM) - Interest Expense

1Y 2Y 5Y Max
9 days ago